Displaying results 61 - 72 of 733
Liver Tumours
Development of liver cancer-derived organoids for drug screening and disease modelling

Development of liver cancer-derived organoids for drug screening and disease modelling

ePosters
View
Liver Tumours
Cabozantinib-Induced Mitochondrial Activation of the cGAS-STING Pathway Enhances the Antitumor Immunity in Experimental Hepatocellular Carcinoma

Cabozantinib-Induced Mitochondrial Activation of the cGAS-STING Pathway Enhances the Antitumor Immunity in Experimental Hepato...

ePosters
View
Liver Tumours
CD147 as a biomarker of hepatocellular carcinoma. Use of AV- CD147 extracellular vesicles as a diagnostic tool.

CD147 as a biomarker of hepatocellular carcinoma. Use of AV- CD147 extracellular vesicles as a diagnostic tool.

ePosters
View
Liver Tumours
Characterization of SLU7 silencing as a new strategy to treat cancer

Characterization of SLU7 silencing as a new strategy to treat cancer

ePosters
View
Liver Tumours
Characterization of the peripheral lymphoid and myeloid compartments in hepatocellular carcinoma patients after combined immunotherapy

Characterization of the peripheral lymphoid and myeloid compartments in hepatocellular carcinoma patients after combined immun...

ePosters
View
Liver Tumours
Circulating tumour DNA analysis for predicting clinical outcomes in advanced liver cancer: insights from tumor fraction, and DELFI score

Circulating tumour DNA analysis for predicting clinical outcomes in advanced liver cancer: insights from tumor fraction, and D...

ePosters
View
Liver Tumours
Antitumoral activity of G9a inhibitors in hepatocellular carcinoma and its potential combination with immune checkpoint inhibitors.

Antitumoral activity of G9a inhibitors in hepatocellular carcinoma and its potential combination with immune checkpoint inhibi...

ePosters
View
Liver Tumours
BAP1 mutations reveal a subgroup of BTC with distinct prognosis and benefit from adjuvant therapy: a retrospective biomarker analysis externally validated in a reconstructed global cohort.

BAP1 mutations reveal a subgroup of BTC with distinct prognosis and benefit from adjuvant therapy: a retrospective biomarker a...

ePosters
View
Liver Tumours
Biopsy proteomic profiling predicts long-term HCC risk in patients with Metabolic dysfunction-Associated Steato-Hepatitis

Biopsy proteomic profiling predicts long-term HCC risk in patients with Metabolic dysfunction-Associated Steato-Hepatitis

ePosters
View
Liver Tumours
Blockade of CD73 expressed by hepatocellular tumour endothelium improves CD8 T cell recruitment

Blockade of CD73 expressed by hepatocellular tumour endothelium improves CD8 T cell recruitment

ePosters
View
Liver Tumours
Blocking RIPK3 impacts mitochondrial dynamics, endoplasmic reticulum stress and inflammation during murine chemical-induced hepatocarcinogenesis

Blocking RIPK3 impacts mitochondrial dynamics, endoplasmic reticulum stress and inflammation during murine chemical-induced he...

ePosters
View
Liver Tumours
Activated Gold-Nanoparticles enhance PD-1 blockade and boost cytotoxic T cell anti-tumor responses in cholangiocarcinoma

Activated Gold-Nanoparticles enhance PD-1 blockade and boost cytotoxic T cell anti-tumor responses in cholangiocarcinoma

ePosters
View